658 related articles for article (PubMed ID: 8449399)
1. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
[TBL] [Abstract][Full Text] [Related]
4. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
5. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
[TBL] [Abstract][Full Text] [Related]
6. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.
Horton LE; Qian Y; Templeton DJ
Cell Growth Differ; 1995 Apr; 6(4):395-407. PubMed ID: 7794807
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
8. Physical interaction of the retinoblastoma protein with human D cyclins.
Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
Connell-Crowley L; Harper JW; Goodrich DW
Mol Biol Cell; 1997 Feb; 8(2):287-301. PubMed ID: 9190208
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Diehl JA; Zindy F; Sherr CJ
Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
Beijersbergen RL; Carlée L; Kerkhoven RM; Bernards R
Genes Dev; 1995 Jun; 9(11):1340-53. PubMed ID: 7797074
[TBL] [Abstract][Full Text] [Related]
14. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
15. D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime H; Quelle DE; Shurtleff SA; Shibuya M; Sherr CJ; Kato JY
Mol Cell Biol; 1994 Mar; 14(3):2066-76. PubMed ID: 8114738
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
17. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
18. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
Paternot S; Arsenijevic T; Coulonval K; Bockstaele L; Dumont JE; Roger PP
Cell Cycle; 2006 Jan; 5(1):61-70. PubMed ID: 16294008
[TBL] [Abstract][Full Text] [Related]
19. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
20. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
Baker GL; Landis MW; Hinds PW
Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]